Anixa Biosciences Inc — Director's Dealing 2012

Sep 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-12

Reporting Person: Titterton Lewis H jr (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-12	8% Convertible Debentures Due 2016	$0.092	P		Acquired	2016-09-16	Common Stock (1630434)	Direct

Footnotes

F1: On September 12, 2012, the reporting person purchased $150,000 principal amount of 8% Convertible Debentures for $150,000 from CopyTele, Inc. in a private placement.